HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-methylthio-6-phenethylaminoadenosine

structure in first source

Also Known As:

BF066

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        2-methylthio-6-phenethylaminoadenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - 2-methylthio-6-phenethylaminoadenosine: 1
  - Ribonucleosides: 49
    - Adenosine: 12431
      - 2-methylthio-6-phenethylaminoadenosine: 1

Experts

1.	Ding, Zhongren: 1 article (01/2012)
2.	Du, Hongguang: 1 article (01/2012)
3.	Liu, Guangda: 1 article (01/2012)
4.	Pan, ChangE: 1 article (01/2012)
5.	Wei, Xunbin: 1 article (01/2012)
6.	Ye, Jianqin: 1 article (01/2012)
7.	Zhang, Si: 1 article (01/2012)
8.	Zhang, Yan: 1 article (01/2012)

Related Diseases

1.	Thrombosis (Thrombus) 01/01/2012 - "In FeCl(3)-injured mouse mesenteric arterial thrombosis model, BF066 prevents thrombus formation effectively, similar to clopidogrel. " 01/01/2012 - "In this study, we report BF066, a novel adenine derivative, inhibits platelet activation and thrombosis via the adenosine receptor (A(2A)) activation and phosphodiesterase (PDE) inhibition. "
2.	Hemorrhage 01/01/2012 - "Intriguingly, at dose achieving similar antithrombotic effect compared to clopidogrel, BF066 does not increase bleeding significantly. " 01/01/2012 - "BF066, a novel dual target antiplatelet agent without significant bleeding."

Related Drugs and Biologics

1.	Purinergic P1 Receptors (Adenosine Receptor)
2.	Phosphoric Diester Hydrolases (Phosphodiesterases)
3.	Adenine
4.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)
5.	Clopidogrel (Plavix)